Japan Approves COVID-19 Antibody Cocktail, 1st Drug for Mild Cases

July 20, 2021
Health Minister Norihisa Tamura A COVID-19 antibody cocktail originated by Regeneron Pharmaceuticals earned special emergency approval in Japan on July 19, becoming the country’s fourth treatment for the disease and its first that can be used in mild cases. “It’s...read more